Alamar Biosciences Files Form 4 on 04/20/2026
Ticker: ALMR · Form: 4 · Filed: Apr 21, 2026 · CIK: 0002104204
Sentiment: neutral
Topics: insider-filing, form-4
TL;DR
Alamar Biosciences filed a Form 4 on 4/20/2026. Ownership changes incoming.
AI Summary
On April 20, 2026, Alamar Biosciences, Inc. filed a Form 4, indicating changes in beneficial ownership of securities. The filing was accepted on the same date. The report period is also April 20, 2026. The company's mailing address is listed as c/o Revvity in Waltham, MA, with a business address at 47071 Bayside Parkway, Fremont, CA.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of changes in beneficial ownership and does not inherently indicate new risks.
Key Numbers
- 04/20/2026 — Filing Date (Date of the Form 4 filing)
Key Players & Entities
- Alamar Biosciences, Inc. (company) — Issuer
- 0001455312-26-000004 (filing_id) — SEC Accession Number
- 2026-04-20 (date) — Filing Date and Period of Report
- Witney Frank (person) — Reporting Person
- 0001455312 (cik) — Reporting Person CIK
- 0002104204 (cik) — Issuer CIK
FAQ
What specific changes in beneficial ownership are reported in this Form 4?
The provided text does not detail the specific changes in beneficial ownership, only that a Form 4 was filed.
Who is the reporting person associated with this filing?
Witney Frank is listed as the reporting person.
What is the CIK number for Alamar Biosciences, Inc.?
The CIK number for Alamar Biosciences, Inc. is 0002104204.
What is the business address of Alamar Biosciences, Inc.?
The business address is 47071 Bayside Parkway, Fremont, CA 94538.
What is the SIC code for Alamar Biosciences, Inc.?
The SIC code is 3826, categorized under Laboratory Analytical Instruments.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 21, 2026 by Witney Frank regarding Alamar Biosciences, Inc. (ALMR). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.